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Abstract 
Adolescents and young adults (AYA) occupy a unique place within the hematologic malignancy 
community due to the challenges they face related to their disease biology, physical, psychosocial 
and economic circumstances, and issues related to access to care and long-term follow-up. Efforts to 
define age-specific (supportive) care needs and targets for intervention in these areas are evolving. 
This review discusses the psychosocial issues AYA with hematologic malignancies are dealing with, 
how these might affect their health-related quality of life (HRQoL), and the challenges in delivering 
high quality supportive care to this underserved population.  
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INTRODUCTION 
Adolescents and young adults (AYA) are recognized as a distinct population within the 
oncology/hematology community due to the unique challenges they face. When compared to 
pediatric and older adult oncology patients, those aged 15-39 years at cancer diagnosis encounter 
differences in tumor biology, psychosocial challenges, issues related to access-to-care and long-term 
follow-up.1,2  
AYA typically present with hematologic malignancies (HM) that span the spectrum from pediatric 
cancers (e.g. acute lymphoblastic leukemia; ALL) to adult tumors (non-Hodgkin lymphoma; NHL), as 
well as tumors that are most common among their age group (Hodgkin lymphoma; HL).3 HM form 
34% of cancers diagnosed among AYA aged 15-19 year (15% HL; 7% NHL; 7% ALL; 5% acute myeloid 
leukemia (AML)), 21% among those aged 20-29 years (10% HL; 6% NHL; 2% ALL; 3% AML) and 11% 
among 30-39 year olds (3% HL; 6% NHL; 1% ALL; 1% AML) in the Western world.1,3-5  For these 
patients, the 5-year overall survival varies between 50 and 95%.6 Although survival in AYA has 
improved over time, progress made in treatments and survival of specific tumors (e.g. ALL and AML) 
lags behind that of children and older adults.5,6 Potential reasons for the lack of progress in survival 
are the diverse and incompletely understood tumor biology,7 insufficient awareness of cancer risk 
and symptoms among patients and healthcare professionals (HCP) resulting in diagnostic delays,8-10 
unequal access to and low participation rates in clinical trials,1 treatment non-adherence rates of 27-
60%11 and limited knowledge among HCP regarding AYA treatment protocols.12 
PSYCHOSOCIAL CHALLENGES AND NEEDS 
Adolescence, emerging and young adulthood are complex phases of life due to the many 
developmental, emotional and social transitions.13 AYA aim to achieve several developmental 
milestones such as completing education, creating their own identity, establishing autonomy, 
forming (romantic) relationships, pursuing gainful employment, becoming financially independent 
and having children.14 A cancer diagnosis and treatment challenges AYAs’ abilities to achieve these 
milestones.15 Although AYA patients with a HM face challenges similar to those of older and younger 
patients, including short-term (e.g. hair loss,16 pain17) and long-term effects of cancer treatment (e.g. 
fatigue18 and cognitive problems19), the consequences are different in this phase of life and more 
pronounced. In the AYA population specifically, treatment decisions should include considerations of 
impact of long-term and late-effects of treatments.20-25 
Education, employment and financial challenges 
Employment and education provide AYA with a sense of identity, income, and frequently health 
insurance for needed treatment and follow-up care.26,27  
 
 Education 
 
Cancer treatment can lead to serious disruption in educational trajectories,28,29 with AYA often 
missing coursework/exams at a time that is crucial to future career development.10 Educational 
settings are an important place for AYA to develop supportive social networks30 and develop a stable 
sense of self-worth.10 AYA describe cancer as a major disruption in the pursuit of educational 
opportunities due to absenteeism, inability to complete exams, and the feeling of being “left 
behind”.28 A recent Dutch study showed that AYA lymphoma (45% HL; 55% NHL) survivors more 
often had a lower educational level compared to a normative population (27% vs. 3%).31 AYA often 
receive inadequate educational support during treatment (help with coursework, postponing exams), 
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and indicate a need for assistance with returning to school.32 Close liaison between schools and 
hospitals is needed. 
 
 Employment  
 
Employment problems are common among AYA with cancer.33 One study conducted in USA showed 
that 33% of AYA (unspecified % HM) versus 27% of healthy controls were not working,34 whereas in 
another American study (9% HM), 24% of AYA patients versus 14% of controls reported 
unemployment due to health issues.33 A more recent American study (4% leukemia, 26% HL, 24% 
NHL) showed that 28% of AYA cancer survivors had not returned to work 15-35 months after 
diagnosis and around 50% reported problems with returning.27 AYA who reported their cancer 
treatment was “very intensive” and those who had to quit work after being diagnosed were more 
likely to report that cancer negatively affected their work, with more than half reporting problems 
with memory and attention.27 AYA with ALL more strongly believed that cancer negatively impacted 
their work plans compared with AYA with other cancers.27 In an English interview study, AYA 
reported feeling “left behind” in their job trajectories compared with their peers and those who had 
previously pursued careers involving physical abilities believed that they needed to adjust their goals 
as a result of their cancer. In addition, some AYA reported discrimination from employers and job 
insecurity due to cancer.28 
Considering that AYA are at a stage in life when entering the workforce successfully will greatly 
influence their future earning and career potential, patients may benefit from the incorporation of 
resources into AYA programs that aid the transition from treatment to occupational pursuits.27 
Future research might focus on effective communication strategies between workers and employers 
to identify appropriate work modifications to help balance the demand of work with adverse 
treatment-related effects, preventing patients from quitting work altogether. 
 
Financial challenges  
Financial toxicity of cancer treatment is especially relevant to AYA with a HM, many of whom 
undergo long, costly therapies such as allogeneic hematopoietic cell transplantation, with side-
effects that may prevent patients from completing education and returning to work.35 An American 
study showed that AYA (72% lymphoma; 28% leukemia) tend to have less productivity, greater 
healthcare expenditures, and increased likelihood of financial problems than patients diagnosed at 
older ages.36 An American study (4% leukemia, 27% HL, 25% NHL) showed that 65-70% of AYA aged 
21-39 years and 51% of AYA aged 15-20 years reported a negative financial impact,29 while another 
American study (unspecified % HM) showed that AYA had lower household incomes compared with 
healthy peers.34 In the same study, AYA reported higher annual medical costs ($7417 vs. $4247 for 
controls) and annual average lost productivity costs due to illness/disability of $2200/year. Some AYA 
with cancer in UK indicated that they need to rely on their parents or other significant others for 
financial support, which can result in feelings of dependency and loss of control.28 In interviews, AYA 
with cancer (59% HM) also describe issues with competing responsibilities and experience a lack of 
financial support for childcare, transportation and elderly care,37 which may also result in lower 
treatment compliance levels among AYA.38  
 
In interviews, one third of American AYA (59% HM) mentioned difficulties in acquiring or maintaining 
health insurance.37 Some lacked insurance before their diagnosis because they could not afford 
coverage and/or felt that they did not need coverage. Others had insurance at the time of diagnosis 
but worried about future insurability (because of losing employment due to treatment). Access and 
affordability of insurance is sometimes also a problem for AYA who are working but do not receive 
coverage through their employers. This can force AYA to seek treatment in an emergency room, a 
suboptimal strategy given crowding, wait times and lack of continuity of care.39 Lack of insurance 
may lead to missed care opportunities and subsequent economic burden including tradeoffs with 
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education and career, using up savings, delinquency on loans, credit card debt, delay in moving out 
from their parents’ home, increased cohabitation, delaying marriage and sometimes difficulty paying 
for basic necessities like rent and food.40 
 
Social relationships and functioning 
Engaging in social and romantic relationships are healthy developmental milestones of any AYA, 
wherein sexuality is explored and future plans to marry and have children are considered.41 A cancer 
diagnosis can disrupt social maturation, the process by which young people develop identity, self-
esteem and self-worth, social cognition, emotional regulation and communication skills that guide 
them throughout the remainder of their lives.10,30,42,43 Several studies showed that AYA with cancer 
report greater challenges in social functioning compared with the general population.44-46  
Peer and family relationships 
Cancer often forces AYA to move home and become dependent on parents or significant others, 
usually after periods of time living independently. For AYA who are married or in committed 
relationships when diagnosed, they are similarly forced into dependence on a spouse or partner 
unexpectedly. In interviews, AYA (59% HM) described the benefits of being cared for and supported, 
but also the challenges of feeling infantilized by their parents, significant others or partner.37 
Emotional development may be negatively affected by learned decisional passivity caused by 
overprotective parenting.47 
 
Furthermore, as AYA with cancer try to deal with or discuss their illness with their parents, partner, 
or significant others they may discover they have quite different coping strategies. Informal 
caregivers may want or need to discuss issues with the AYA that he/she does not wish to discuss, or 
vice versa. Some AYA desire to protect their family members by shielding things they themselves 
worry about, possibly out of guilt for what their parents, significant others, or partner are going 
through, or because they can see how upset family members are.48 Moreover, in qualitative research 
AYA patients with dependents experience the drive to keep pushing forward as a function of the 
need to take care of others (e.g. children), even when they feel sick.37 This reflects the intertwined 
experiences of fighting cancer and being a parent/caregiver, a non-normative challenge for an AYA. 
Also, children of AYA cancer patients may go through a distressing time, behavioral problems and 
restrictive cognitive and physical functioning are reported.49  
 
For many AYA, having cancer is catalytic in changing social relationships, either enhancing closeness 
or creating distance. From the perspective of friends, a cancer diagnosis can be a source discomfort, 
responding to ill friends by avoiding them. Isolation and alienation are commonly reported among 
AYA with cancer, particularly as they miss life experiences being shared by their healthy 
peers.50 Disruptions in the socialization process can result in impaired social skills, which may lead to 
diminished participation, social anxiety and loneliness.47 In other qualitative studies, AYA frequently 
report difficulties maintaining or making new relationships as they feel anxious about ‘fitting into” 
their peer group again.37,51,52 Changes in body image often lead to feelings of insecurity and make 
AYA feel different from peers.53-59 An American study showed that AYA (27% HL, 25% NHL, 4% ALL) 
who reported that cancer had an impact on their close relationships were more likely to desire 
information on how to talk about their cancer with others.60 Respectively, 27%, 29% and 5% of the 
HL, NHL and ALL patients had an information need on how to talk about their cancer experience with 
family and friends.60  
 
Marital relationships  
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Marriage is another important social milestone for many AYA. An American study found that fewer 
AYA (6% HM) with cancer were currently married (58 vs. 64%) and more had been divorced or 
separated (18 vs. 10%) compared with age-matched controls.61 Twenty-five percent of AYA reported 
that cancer negatively impacted their relationship with their spouse/significant other. It could be 
hypothesized that the emotional and financial burden of a cancer diagnosis could lead to marital 
distress. In a qualitative study (59% HM), divorced AYA patients indicated that their cancer 
experience catalyzed the breakups because their partners were not willing or able to support them 
through their disease.37 AYA also discussed challenges initiating new romantic relationships. Negative 
body image, low self-esteem, infertility concerns, or feelings of “abnormality” as a result of cancer 
and its treatment might negatively influence AYAs’ readiness and ability to engage in romantic 
relationships.37,62,63 
 
Future research is needed to examine the complex and nuanced ways that cancer experiences affect 
relationships between AYA and their significant others, this will ultimately help to develop (digital) 
social support interventions which will support AYA in developing new social and maintaining existing 
contacts.30 
 
 Starting a family 
 
Around 75% of AYA who have not had children at cancer diagnosis express a wish for future 
biological offspring.64-67 Cancer treatments have the potential to destroy reproductive cells and can 
place women at risk for acute ovarian failure/premature menopause and men for 
temporary/permanent azoospermia.68,69 There are several fertility preservation options available,70,71 
however counseling hematologic AYA patients about fertility threats is challenging due to the 
undefined risk and variable timing of gonadal failure, indeterminate likelihood and timing of gonadal 
recovery, and the unknown risks and efficacy of nonstandard but immediately available fertility 
preservation options.70   
Despite the available fertility preservation options, discussion, referrals and treatment are 
inconsistent, and many AYA initiate treatment without discussion or opportunity for fertility 
preservation.72,73-76 For example, an American study showed that, depending on tumor type and sex, 
17-83% of AYA patients with HM discussed fertility preservation with their HCP.76 In qualitative 
research, AYA reported false beliefs, unrealistic expectations and uncertainty regarding their 
reproductive potential and options.77,78 Reproductive concerns in AYA cancer survivors have been 
associated with grief, low self-esteem, an altered sense of identity79 and can negatively affect dating, 
social relationships, and life planning.80,81 AYA with confirmed infertility reported regret for not 
questioning infertility risks, guilt for their current partner or fear of never finding a partner79, and 
long-term distress.64  
 
These results emphasize that HCP should be better educated about fertility risks and should inform 
AYA patients about their risks and fast evolving opportunities for fertility preservation.72  
 
Sexual functioning and intimacy 
 
AYA may experience cancer- and treatment-related sexual dysfunctions.82 Treatment can cause 
problems with erection, premature ejaculation, early menopause, vaginal dryness, shrinking, loss of 
elasticity, which can all result in discomfort during intercourse and interfere with the patients’ ability 
to be interested in or enjoy sex.83  
An American study showed that 49% of AYAs (28% HL, 24% NHL, 4% ALL) reported negative effects 
on sexual function 1-year post-cancer diagnosis and 70% of those persisted in their negative 
perceptions 2-years after diagnosis. Those reporting a negative impact were more likely to report 
that their diagnosis had a negative effect on physical appearance.53 A Finnish study showed that 
female leukemia survivors (mean age at study 20.1 years) had more restrictive images of sexuality, 
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and their attitudes, especially those concerning sexual pleasure, were more negative than those of 
healthy controls.84  
In addition, short- and long-term effects of treatment (e.g. fatigue, graft versus host disease, nausea, 
neuropathy) may hinder intimacy and interest in sexual activity85. Patients may feel embarrassed that 
others see them differently because of physical changes, such as weight gain/loss, hair loss, swelling, 
scars or the presence of a central line/port. All these treatment-related effects and sexual 
dysfunctions accompanied by changes in self-esteem (different sense of self-worth and self-
confidence) may have (enduring) negative effects patients’ and their partners’ sex life. 84,90,86 
One study showed that when sexual problems were not discussed, patients were likely to believe 
that sexual dysfunction and treatment-related damages could not be treated86. These results 
emphasize the need to inform about and improve post-cancer treatments addressing sexuality for 
AYA and their partners.87 
 
Psychological issues 
 
Several studies have shown that rates of psychological distress are significantly greater among AYA 
when compared with older patients.55 Older age and previous life experiences have been recognized 
as protective factors as they are related to highly developed coping skills.88 More so than childhood 
cancer patients, AYA have the cognitive capacity to understand the severity of their illness and 
frequently demonstrate persistent distress. A recent American study among AYA treated for ALL, NHL 
or HL showed that 23% met the criteria for anxiety, 28% for depression, and 13% for post-traumatic 
stress, respectively, while 46% overall demonstrated post-traumatic stress symptomatology.89 Thirty-
nine percent were impaired in one or more psychological domain. No differences in psychological 
morbidity were observed between patients on-treatment compared to early survivors. A Dutch study 
showed that 69% of AYA cancer patients aged 18-35 years (14% HM) reported fear of 
recurrence/progression.90 
 
Alterations in physical appearance, e.g. scars of biopsies and central lines, weight changes and hair 
loss, not only make AYA feel different from peers but may also adversely affect maturational 
processes including development of self-esteem and identity.58,91 Fear the body will never return to 
its original appearance, of not being recognized by others, or of being mistaken for an individual of 
the opposite sex often lead to shame, social isolation, and regressive behaviors.15,63 
 
Interestingly, HCPs’ perceptions of their AYA patients’ psychological morbidity is not related to AYA 
patients’ own perceptions,89 suggesting HCP are not consistently assessing distress in AYA patients 
during clinic visits. AYA themselves may delay reporting distress-related symptoms to providers 
because of a passive-avoidant coping style, individual patient’s effort to cope with the disease alone 
or a fear of stigmatization following acceptance of being diagnosed with a psychological illness. 
Several American studies show AYA repeatedly report that their psychosocial needs are not met 
throughout the cancer experience,78,92-94 e.g. 41% of AYA reported an unmet need for psychological 
counseling 12 months after diagnosis.92  
 
Psychological interventions targeting adults or children are not adequate to reduce distress among 
AYA.95 Interventions for AYA must manage competing demands for time such as school, work, and 
family.96 Novel AYA-focused psychosocial interventions delivered in AYA-friendly platforms (e.g. 
social media) are currently being evaluated.97 
 
End-of-life challenges 
The diagnosis of advanced cancer may be particularly distressing for AYA. Young people have had less 
time to learn from other adverse life experiences to help manage the consequences of advanced 
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disease. They face many complex decisions but may lack the fully developed executive functioning 
and abstract thinking necessary for medical decision making and coping with uncertainty.98 During 
young adulthood, when new parenthood is common, fears about the welfare of children and 
significant others and about leaving them behind may add to distress in patients facing end of 
life.99,100  
 
A Canadian interview study among AYA with advanced cancer aged 18-35 years, showed that 
patients experience their diagnosis as isolating (e.g. feeling misunderstood or alienated) and 
unexpected (e.g. cancer is a disease of older adults) and feel forcefully removed from the normal life 
trajectory.101 In an American interview study AYA (20-40 years) reported anticipatory grief over their 
life that has not yet been lived,102 a psychological state that may be difficult for AYA to process, and 
may be reluctant to face the irreversibility and progression of their disease. 102 This may lead to 
delays in the receipt of appropriate palliative and end-of-life care. An American study showed that 
AYA (26% HM) who die in the hospital tend to utilize palliative care services very late in the disease 
trajectory and often undergo aggressive treatment until death is near.103 Early use of palliative care 
would have great utility in providing physical, psychosocial and spiritual support.  
 
HEALTH-RELATED QUALITY OF LIFE 
 
The combination of trying to achieve developmental milestones while coping with a life-threatening 
disease may have a negative impact on the HRQoL of AYA.104 Two recent review papers show that 
AYA with cancer experience worse HRQoL compared with a normative population.105,106 Studies 
conducted among AYA with HM support these findings.31,107-109 Risk factors for poor HRQoL were low 
socio-economic status, female sex, unemployment, high levels of distress and physical 
symptoms.31,107,109 A recent longitudinal study conducted in USA showed that most improvements in 
HRQoL (n=141; 11% HL, 8% NHL, 26% leukemia) take place in the first year after diagnosis,110 
presumably once AYA have acknowledged and adapted to new life routines that revolve around 
treatments and visits to clinics, hospitals, and doctors’ offices. In the second year after cancer 
diagnosis no significant HRQoL improvements were found. The transition from cancer patient to off-
treatment survivor is often fraught with new challenges as AYA cancer survivors are confronted with 
survivorship concerns about their future lives.29 AYA patients may therefore benefit from supportive 
care interventions administered during the second year following diagnosis to help AYA near 
completion of therapy [re]-normalize their lives. 
HRQoL assessment in clinical practice throughout the disease trajectory is important as it can 
facilitate communication, improve symptom control and patient satisfaction and reduce hospital 
admissions.111 In order to integrate HRQoL assessments in routine clinical care, it is essential to have 
measures available that capture the full range of issues relevant to AYA with hematologic 
malignancies. Generic HRQoL instruments (e.g. EORTC-QLQ-C30,112 FACT-G113) do not efficiently 
capture the unique experiences of this group. Tumor-specific questionnaires (e.g. EORTC modules for 
lymphoma and leukemia,114 FACT-Lym115/FACT-Leu116) accompanied by age-specific questionnaires 
(e.g. EORTC-AYA)117 should be administered to assess the impact of treatments, provide optimal 
supportive care and ultimately translate into meaningful outcomes for AYA with HM. 
 
Up to now, most studies are limited by heterogeneous study samples of AYA patients with different 
tumor types and sub-analyses were rarely performed. Future research should explore the specific 
challenges of AYA with hematologic malignancies in more detail. 
 
DELIVERING QUALITY SUPPORTIVE CARE 
AYA have often be identified as the “lost tribe”:118 Neither pediatric nor adult oncology/hematology 
departments are able to provide age-appropriate care single-handedly to this group. In general, there 
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is strong potential benefit from closer collaboration between pediatric and adult hematologists to 
improve long-term outcomes.119,120 Studies show that AYA with cancer report high levels of unmet 
supportive care needs,35,121 especially with regard to receiving age-specific information and 
psychosocial supportive care.92 In recent years, several AYA programs were formed in an attempt to 
bridge the gap and address unmet supportive care needs.2,122-124,123,125 
 
Multidisciplinary supportive care  
 
As a result of the complexity of their care, the lack of experience navigating medical systems and the 
variety of age-specific challenges, AYA will likely benefit from an AYA multidisciplinary team 
approach. In addition to routine medical professionals, this may include specialized nurses, fertility 
and sexual experts, dieticians, physical therapists, psychologists,  and social workers.126 Early 
intervention by the multidisciplinary care team is essential to provide effective (psychosocial) 
support to AYA including fertility and sexuality counseling, programs to maximize education and 
vocational functioning, concrete financial and housing support, and access to age-specific 
information.14 Addressing physical, psychosocial and economic challenges early in the disease 
trajectory will help reduce the impact of long-term effects. Supportive care for family members 
should also be discussed.  
Given the relatively small number of AYA as part of the whole cancer population diagnosed each 
year, it is not realistic to expect every hospital to possess all the personnel, facilities, and 
components needed for the best treatment of AYA; or to create own AYA programs.127 For 
community hospitals, an oncology clinical nurse could specialize as AYA nurse specialist. Nurses 
spend ongoing and dedicated time with patients and are therefore well positioned to support and 
educate them. AYA specialist nurses can provide patients with developmentally appropriate 
educational resources and support, are critical for managing care transitions and engaging experts 
from other disciplines, and could function as a resource for colleagues who are less familiar with AYA 
age-specific needs.128 In complex cases, an AYA can be referred to a center with a specialized AYA 
program. In larger centers, an AYA clinical nurse specialist could be introduced to improve awareness 
of clinical trials, assist in enrolling AYA in these trials, promote multidisciplinary discussions and care, 
and provide access or referrals to age-appropriate psychosocial care or health-promoting 
interventions, altogether providing patients with a sense of continuity of care.127 
 
Inpatient and outpatient facilities 
One of the most commonly expressed feelings by AYA cancer patients is that they do not belong to 
any specific group or place.123 The healthcare environment can support the maintenance of a sense 
of normalcy by having accessible visiting hours14 and availability of dedicated, social space facilities 
(e.g. to play games) to suit the age-specific needs. Studies have also shown that support received 
from other AYA cancer patients is incredibly important.129 Inpatient wards and social space facilities 
within the hospital provide AYA the opportunity to connect, share experiences, learn from each 
other, and feel genuinely understood.130 This is particularly important for AYA who have to undergo 
extensive in-patient treatments like stem cell transplantation. For the large proportion of AYA also 
receiving out-patient treatment, AYA support interventions, such as face-to-face weekly meetings, 
online communities and retreats, have been shown  to significantly reduce feelings of social isolation 
and improve knowledge and problem-solving skills.130-132 
Training and education of HCP 
 
HCP and treating institutions can reasonably be expected to have knowledge of medical and 
supportive care opportunities for AYA with cancer and to provide referrals to appropriate expert 
centers when necessary.127 Currently, most HCP training programs do not address AYA-specific 
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issues, resulting in poor recognition of AYA cancer risk and an inadequate response to their physical 
and psychosocial needs.2 An AYA module should be required for HCP of different disciplines.42  
 
Until now, several countries have made recommendations about what AYA cancer care should look 
like.2,133,134 The current AYA programs need to be evaluated in terms of improvements in patient 
satisfaction, HRQoL, survival and clinical outcomes (e.g. trial participation). Studies need to provide 
objective evidence demonstrating the efficacy of critical components of the AYA care programs in 
order to create evidence-based guidelines, referral pathways and education.127,135 In addition, the 
AYA oncology agenda should be moved beyond high-income countries to support those in less 
privileged circumstances.136  
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